HOUSE BILL 1310
J1 (5lr2600)
ENROLLED BILL
— Health and Government Operations/Finance —
Introduced by Delegate Bhandari
Read and Examined by Proofreaders:
_______________________________________________
Proofreader.
_______________________________________________
Proofreader.
Sealed with the Great Seal and presented to the Governor, for his approval this
_______ day of _______________ at ________________________ o’clock, ________M.
______________________________________________
Speaker.
CHAPTER ______
1 AN ACT concerning
2 Prescription Drug Repository Program – Out–of–State Pharmacies Revisions
3 FOR the purpose of defining “licensed pharmacy” for the purpose of allowing pharmacies
4 licensed in another state to be designated by the State Board of Pharmacy as a
5 repository under the Prescription Drug Repository Program altering the Prescription
6 Drug Repository Program, including by allowing certain entities located in another
7 state to participate in the Program as drop–off sites and repositories, including
8 over–the–counter drugs under the Program, and altering the individuals who are
9 eligible to receive drugs or medical supplies under the Program; altering the persons
10 for whom and the activities with respect to which certain immunity is provided under
11 the Program; and generally relating to the Prescription Drug Repository Program.
12 BY repealing and reenacting, with amendments,
13 Article – Health – General
14 Section 15–601 through 15–609
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment.
Italics indicate opposite chamber/conference co mm i tte e a m en dm en ts*. hb1310*

2 HOUSE BILL 1310
1 Annotated Code of Maryland
2 (2023 Replacement Volume and 2024 Supplement)
3 BY repealing and reenacting, without amendments,
4 Article – Health – General
5 Section 15–605, 15–607, and 15–609
6 Annotated Code of Maryland
7 (2023 Replacement Volume and 2024 Supplement)
8 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
9 That the Laws of Maryland read as follows:
10 Article – Health – General
11 15–601.
12 (a) In this subtitle the following words have the meanings indicated.
13 (b) “Board” means the State Board of Pharmacy.
14 (c) “DISPENSE” MEANS TO PROVIDE:
15 (1) A PRESCRIPTION DRUG OR MEDICAL SUPPLY IN ACCORDANCE
16 WITH A PRESCRIPTION; OR
17 (2) AN OVER–THE–COUNTER DRUG OR MEDICAL SUPPLY.
18 (D) “Drop–off site” means a pharmacy or, other health care facility, OR OTHER
19 ENTITY PARTICIPATING IN A DRUG DONATION OR REPOSITORY PROGRAM AND
20 designated by the Board that:
21 (1) Has voluntarily agreed to accept donated prescription drugs,
22 OVER–THE–COUNTER DRUGS, or medical supplies; and
23 (2) IS LOCATED WITHIN THE STATE OR IN ANOTHER STATE; AND
24 (3) Does not have a final disciplinary order issued against it by a health
25 occupations board.
26 (D) “LICENSED PHARMACY” MEANS A PHARMACY LICENSED BY THE BOARD
27 OR A PHARMACY LICENSED IN ANOTHER STATE.
28 [(d)] (E) “ELIGIBLE PATIENT” MEANS AN INDIVIDUAL WHO, THROUGH
29 SELF–ATTESTATION, IS INDIGENT, UNINSURED, UNDERINSURED, OR ENROLLED IN A
30 PUBLIC HEALTH BENEFITS PROGRAM.

HOUSE BILL 1310 3
1 (F) “Program” means the Prescription Drug Repository Program.
2 [(e)] (F) (G) “Repository” means a licensed pharmacy that:
3 (1) Does IF THE LICENSED PHARMACY IS LOCATED IN THE STATE,
4 DOES not have a final disciplinary order issued against it by the Board of Pharmacy OR,
5 FOR AN OUT–OF–STATE LICENSED PHARMACY, THE APPLICABLE REGULATORY
6 AUTHORITY;
7 (2) Has voluntarily agreed to participate in the Program; and
8 (3) IS LOCATED IN THE STATE OR IN ANOTHER STATE; AND
9 (4) Has been approved by the Board to:
10 (i) Accept donated prescription drugs, OVER–THE–COUNTER
11 DRUGS, or medical supplies from a designated drop–off site;
12 (ii) Dispense the donated prescription drugs, OVER–THE–COUNTER
13 DRUGS, or medical supplies to needy individuals ELIGIBLE PATIENTS; or
14 (iii) Dispose of prescription drugs, OVER–THE–COUNTER DRUGS, or
15 medical supplies not accepted for dispensing to needy individuals ELIGIBLE PATIENTS.
16 (H) “TAMPER–EVIDENT PACKAGING” MEANS A PACKAGING SYSTEM THAT:
17 (1) MAY INVOLVE AN IMMEDIATE–CONTAINER AND CLOSURE SYSTEM,
18 SECONDARY–CONTAINER OR CARTON SYSTEM, TERTIARY–CONTAINER SYSTEM, OR
19 OTHER COMBINATION OF SYSTEMS INTENDED TO PROVIDE A VISUAL INDICATION OF
20 PACKAGE INTEGRITY;
21 (2) MAY CONTAIN UNIT–DOSE OR MULTI–DOSE CONTENTS; AND
22 (3) HAS ONE OR MORE INDICATORS OR BARRIERS TO ENTRY THAT:
23 (I) IF BREACHED OR MISSING, CAN REASONABLY BE EXPECTED
24 TO PROVIDE VISIBLE EVIDENCE TO CONSUMERS THAT TAMPERING HAS OCCURRED;
25 AND
26 (II) IF HANDLED IN A REASONABLE MANNER DURING
27 MANUFACTURE, DISTRIBUTION, OR RETAIL DISPLAY, IS DESIGNED TO REMAIN
28 INTACT.

4 HOUSE BILL 1310
1 15–602.
2 (a) There is a Prescription Drug Repository Program regulated by the Board.
3 (b) The purpose of the Program is to:
4 (1) Accept prescription drugs, OVER–THE–COUNTER DRUGS, and medical
5 supplies donated for the purpose of dispensing to [needy individuals] ELIGIBLE PATIENTS;
6 and
7 (2) Accept prescription drugs, OVER–THE–COUNTER DRUGS, and medical
8 supplies returned to a pharmacy for the purpose of proper disposal.
9 15–603.
10 (a) Except as provided in subsection (b) of this section, the Program may accept for
11 the purpose of dispensing only:
12 (1) Prescription drugs AND OVER–THE–COUNTER DRUGS in their
13 original unopened, sealed, and tamper–evident [unit dose] packaging, INCLUDING DRUGS
14 THAT HAVE BEEN PACKAGED BY A MANUFACTURER OR HAVE BEEN REPACKAGED BY
15 AN ENTITY AUTHORIZED TO REPACKAGE DRUGS IN THE STATE IN WHICH THE ENTITY
16 IS LOCATED; and
17 (2) Medical supplies in their original unopened and sealed packaging.
18 (b) The Program may accept and dispense prescription drugs AND
19 OVER–THE–COUNTER DRUGS packaged in single unit doses when the outside packaging
20 is opened if the single unit dose packaging is undisturbed.
21 (c) (1) The Program may not accept prescription drugs, OVER–THE–COUNTER
22 DRUGS, or medical supplies for dispensing that:
23 [(1)] (I) [Bear] EXCEPT AS PROVIDED IN PARAGRAPH (2) OF THIS
24 SUBSECTION, BEAR an expiration date that is less than 90 days from the date the drug is
25 donated;
26 [(2)] (II) May be adulterated, according to the standards of § 21–216 of this
27 article; or
28 [(3)] (III) Belong to a category of unacceptable drugs established under §
29 15–608(b)(1) of this subtitle.
30 (2) (I) THE PROGRAM MAY ACCEPT PRESCRIPTION DRUGS AND
31 OVER–THE–COUNTER DRUGS THAT BEAR AN EXPIRATION DATE THAT IS LESS THAN

HOUSE BILL 1310 5
1 90 DAYS FROM THE DATE THE DRUG IS DONATED IF THE PRESCRIPTION DRUG OR
2 OVER–THE–COUNTER DRUG IS IN HIGH DEMAND.
3 (II) IF THE PROGRAM ACCEPTS A PRESCRIPTION DRUG OR
4 OVER–THE–COUNTER DRUG UNDER SUBPARAGRAPH (I) OF THIS PARAGRAPH, THE
5 PROGRAM MAY NOT DISPENSE THE PRESCRIPTION DRUG OR OVER–THE–COUNTER
6 DRUG IF THE EXPIRATION DATE OCCURS DURING THE TIME PERIOD FOR WHICH THE
7 PRESCRIPTION DRUG OR OVER–THE–COUNTER DRUG IS PRESCRIBED.
8 15–604.
9 (a) (1) Any person may donate prescription drugs, OVER–THE–COUNTER
10 DRUGS, or medical supplies to the Program.
11 (2) THE PROGRAM MAY RECEIVE DONATED PRESCRIPTION DRUGS,
12 OVER–THE–COUNTER DRUGS, OR MEDICAL SUPPLIES FROM ANY PERSON.
13 (b) Prescription drugs, OVER–THE–COUNTER DRUGS, or medical supplies may
14 be donated only [at] TO a drop–off site designated for that purpose by the Board.
15 (c) A drop–off site LOCATED IN THE STATE shall:
16 (1) Require a donor to complete and sign a donor form releasing the
17 prescription drugs, OVER–THE–COUNTER DRUGS, or medical supplies to the Program;
18 (2) Store donated prescription drugs, OVER–THE–COUNTER DRUGS, and
19 medical supplies in a secure location used exclusively for the Program; and
20 (3) Forward, at the cost of the designated drop–off site, all donated
21 prescription drugs, OVER–THE–COUNTER DRUGS, and medical supplies to a [central]
22 repository.
23 (d) A drop–off site LOCATED IN THE STATE may not:
24 (1) Dispense donated prescription drugs, OVER–THE–COUNTER DRUGS,
25 or medical supplies;
26 (2) Resell prescription drugs, OVER–THE–COUNTER DRUGS, or medical
27 supplies donated to the Program; or
28 (3) Charge a fee for accepting a donation.
29 (E) CONSISTENT WITH ITS APPROVAL BY THE BOARD, AN ENTITY LOCATED
30 IN ANOTHER STATE:

6 HOUSE BILL 1310
1 (1) MAY PARTICIPATE IN THE PROGRAM AS A DROP–OFF SITE; AND
2 (2) MAY ACCEPT DONATED PRESCRIPTION DRUGS,
3 OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES FROM A PERSON, UNLESS
4 OTHERWISE PROHIBITED BY FEDERAL LAW OR THE LAWS OF THE STATE IN WHICH
5 THE ENTITY IS LOCATED.
6 15–605.
7 (a) The Board may approve Medbank of Maryland, Inc., or another A licensed
8 pharmacy, to be a repository.
9 (b) Consistent with its approval by the Board, a repository LOCATED IN THE
10 STATE shall:
11 (1) Accept only donated prescription drugs, OVER–THE–COUNTER
12 DRUGS, and medical supplies forwarded by designated drop–off sites;
13 (2) Inspect all donated prescription drugs, OVER–THE–COUNTER DRUGS,
14 and medical supplies;
15 (3) Accept for dispensing to needy individuals ELIGIBLE PATIENTS only
16 those donated prescription drugs, OVER–THE–COUNTER DRUGS, and medical supplies
17 that meet the requirements of § 15–603 of this subtitle;
18 (4) Dispose of donated prescription drugs, OVER–THE–COUNTER DRUGS,
19 and medical supplies not accepted for dispensing to needy individuals ELIGIBLE PATIENTS
20 in accordance with State and federal law;
21 (5) Maintain a separate inventory of donated prescription drugs,
22 OVER–THE–COUNTER DRUGS, and medical supplies;
23 (6) Store donated prescription drugs, OVER–THE–COUNTER DRUGS, and
24 medical supplies in a secure location used exclusively for the Program;
25 (7) Maintain separate prescription files for patients receiving donated
26 prescription drugs and medical supplies; and
27 (8) Obliterate from the labels of donated prescription drugs and medical
28 supplies any information specific to the patient for whom the donated prescription drugs,
29 OVER–THE–COUNTER DRUGS, and medical supplies were originally dispensed OR
30 OTHERWISE PROVIDED TO THE PATIENT.
31 (c) A repository LOCATED IN THE STATE shall dispense donated prescription
32 drugs, OVER–THE–COUNTER DRUGS, and medical supplies only:

HOUSE BILL 1310 7
1 (1) To an individual who meets the requirements of § 15–606 § 15–606(A)
2 of this subtitle;
3 (2) On a new prescription, in the case of a prescription drug or medical
4 supply that requires a prescription; and
5 (3) In accordance with State and federal laws pertaining to:
6 (i) Storage, distribution, and dispensing of prescription drugs; and
7 (ii) Confidentiality of patient information.
8 (d) A repository LOCATED IN THE STATE may:
9 (1) Charge a fee, not to exceed $10, for each prescription drug,
10 OVER–THE–COUNTER DRUG, or medical supply dispensed; and
11 (2) Dispense a donated prescription drug, OVER–THE–COUNTER DRUG,
12 or medical supply by mail, provided that the repository informs the patient that a delay
13 may be entailed.
14 (e) A repository may not establish or maintain a waiting list for any prescription
15 drug, OVER–THE–COUNTER DRUG, or medical supply dispensed by the Program.
16 (f) A pharmacy may accept prescription drugs, OVER–THE–COUNTER DRUGS,
17 and medical supplies taken to the pharmacy for disposal only if the pharmacy is approved
18 by the Board as a repository for this purpose.
19 (g) CONSISTENT WITH ITS APPROVAL BY THE BOARD, AN ENTITY LOCATED
20 IN ANOTHER STATE:
21 (1) MAY PARTICIPATE IN THE PROGRAM AS A REPOSITORY; AND
22 (2) SHALL DISPENSE DONATED PRESCRIPTION DRUGS,
23 OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES TO RESIDENTS OF THE STATE
24 ONLY IN ACCORDANCE WITH:
25 (I) FEDERAL LAW;
26 (II) LAWS OF THE STATE IN WHICH THE ENTITY IS LOCATED
27 PERTAINING TO STORAGE AND DISTRIBUTION OF PRESCRIPTION DRUGS,
28 OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES; AND
29 (III) STATE LAWS PERTAINING TO NONRESIDENT PHARMACIES.

8 HOUSE BILL 1310
1 (H) The Program may not require a private entity to establish, operate, or fund a
2 drop–off site or disposal program.
3 (h) (I) The Department shall develop a process for providing information about the
4 availability of the State’s earned income tax credit established under § 10–704 of the Tax –
5 General Article to each individual receiving donated prescription drugs and medical
6 supplies from the A repository.
7 (J) A PERSON DONATING, TRANSFERRING, OR RECEIVING PRESCRIPTION
8 DRUGS, OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES, OR FACILITATING
9 THE DONATION, TRANSFER, OR RECEIPT, IN ACCORDANCE WITH THIS SUBTITLE MAY
10 NOT BE REQUIRED TO HOLD A WHOLESALE DISTRIBUTION LICENSE.
11 (K) A REPOSITORY LOCATED IN ANOTHER STATE OPERATING PRIMARILY
12 FOR THE PURPOSE OF PARTICIPATING IN A DRUG DONATION OR REPOSITORY
13 PROGRAM MAY NOT BE REQUIRED TO POSSESS A COMPREHENSIVE OR MINIMUM
14 SUPPLY OF PRESCRIPTION DRUGS, OVER–THE–COUNTER DRUGS, OR MEDICAL
15 SUPPLIES.
16 (L) A REPOSITORY LOCATED IN THE STATE MAY TRANSFER DONATED
17 PRESCRIPTION DRUGS, OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES TO:
18 (1) ANOTHER REPOSITORY LOCATED IN THE STATE; OR
19 (2) A DROP–OFF SITE LOCATED IN ANOTHER STATE, A REPOSITORY
20 LOCATED IN ANOTHER STATE, OR ANOTHER ENTITY LOCATED IN ANOTHER STATE
21 THAT PARTICIPATES IN A DRUG DONATION OR REPOSITORY PROGRAM IN
22 ACCORDANCE WITH THE LAWS OF THE STATE IN WHICH THE ENTITY IS LOCATED
23 ONLY IF THERE IS NO NEED FOR THE DONATED PRESCRIPTION DRUGS,
24 OVER–THE–COUNTER DRUGS, OR MEDICAL SUPPLIES FOR USE BY ELIGIBLE
25 PATIENTS IN THE STATE, AS DETERMINED BY THE TRANSFERRING REPOSITORY.
26 (M) UNLESS OTHERWISE PROHIBITED BY FEDERAL LAW OR THE LAWS OF
27 THE STATE IN WHICH IT IS LOCATED, A DROP–OFF SITE OR REPOSITORY LOCATED IN
28 ANOTHER STATE MAY PERFORM AND RECEIVE:
29 (1) INTRACOMPANY TRANSFERS OF DONATED PRESCRIPTION DRUGS,
30 OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES; AND
31 (2) TRANSFERS OF DONATED PRESCRIPTION DRUGS,
32 OVER–THE–COUNTER DRUGS, AND MEDICAL SUPPLIES FROM DROP–OFF SITES
33 LOCATED IN ANOTHER STATE, REPOSITORIES LOCATED IN ANOTHER STATE, OR

HOUSE BILL 1310 9
1 OTHER ENTITIES PARTICIPATING IN A DRUG DONATION OR REPOSITORY PROGRAM
2 IN ACCORDANCE WITH THE LAWS OF THE STATE IN WHICH THE ENTITY IS LOCATED.
3 15–606.
4 (A) To be eligible to receive donated prescription drugs, OVER–THE–COUNTER
5 DRUGS, or medical supplies FROM A REPOSITORY LOCATED IN THE STATE, an
6 individual [shall] MUST:
7 (1) Be a resident of the State; and
8 (2) Be [a needy] AN ELIGIBLE patient[, as indicated by the individual’s
9 health care practitioner].
10 (B) TO BE ELIGIBLE TO RECEIVE DONATED PRESCRIPTION DRUGS,
11 OVER–THE–COUNTER DRUGS, OR MEDICAL SUPPLIES FROM A REPOSITORY LOCATED
12 IN ANOTHER STATE, AN INDIVIDUAL MUST BE AN ELIGIBLE PATIENT.
13 15–607.
14 (a) This section applies to:
15 (1) A person that donates prescription drugs, OVER–THE–COUNTER
16 DRUGS, or medical supplies to the Program;
17 (2) A drop–off site;
18 (3) A repository;
19 (4) The Board; and
20 (5) Pharmacists;
21 (6) PHARMACY TECHNICIANS; AND
22 (7) STAFF EMPLOYED BY OR VOLUNTEERING FOR AN ENTITY
23 PARTICIPATING IN THE PROGRAM.
24 (b) For matters related to donating, accepting, TRANSFERRING, disposing of, or
25 dispensing prescription drugs, OVER–THE–COUNTER DRUGS, or medical supplies under
26 the Program, OR FACILITATING THE DONATION, ACCEPTANCE, TRANSFER,
27 DISPOSITION OF, OR DISPENSING, a person described in subsection (a) of this section
28 that acts in good faith may not be subject to:
29 (1) Criminal prosecution; or

10 HOUSE BILL 1310
1 (2) Liability in tort or other civil action for injury, death, or loss to person
2 or property.
3 (c) A drug manufacturer acting in good faith may not be subject to criminal
4 prosecution or liability in tort or other civil action for injury, death, or loss to person or
5 property for matters related to the donation, acceptance, or dispensing of a drug
6 manufactured by the drug manufacturer that is donated by any person under the Program,
7 including liability for failure to transfer or communicate product or consumer information
8 or the expiration date of the donated drug.
9 15–608.
10 (a) On or before January 1, 2007, and in consideration of the recommendations of
11 the Task Force on the Establishment of a Prescription Drug Repository Program, the Board
12 shall adopt regulations governing the Program.
13 (b) The regulations shall include:
14 (1) Categories of drugs that a repository will not accept, including a
15 statement as to why the drug is ineligible for donation;
16 (2) A standard form each donor DONATING TO A DROP–OFF SITE
17 LOCATED IN THE STATE must sign stating that the donor is the owner of the drugs and
18 intends to voluntarily donate them to the Program;
19 (3) Requirements for designation of drop–off sites to accept donated
20 prescription drugs, OVER–THE–COUNTER DRUGS, and medical supplies under the
21 Program;
22 (4) Requirements for designation of repositories to dispense or dispose of
23 donated prescription drugs, OVER–THE–COUNTER DRUGS, and medical supplies under
24 the Program;
25 (5) Standards and procedures for DROP–OFF SITES AND REPOSITORIES
26 LOCATED IN THE STATE RELATED TO accepting, safely storing, dispensing, shipping, and
27 disposing of donated prescription drugs, OVER–THE–COUNTER DRUGS, and medical
28 supplies;
29 (6) Standards and procedures for REPOSITORIES LOCATED IN THE
30 STATE RELATED TO inspecting donated prescription drugs, OVER–THE–COUNTER
31 DRUGS, and medical supplies intended for dispensing to determine that:
32 (i) The [original packaging is:
33 1. Sealed and tamper–evident; and

HOUSE BILL 1310 11
1 2. In the case of prescription drugs, in the undisturbed single
2 unit dose packaging; and] PRESCRIPTION DRUGS AND OVER–THE–COUNTER DRUGS
3 ARE IN ORIGINAL UNOPENED, SEALED, AND TAMPER–EVIDENT PACKAGING, WHICH
4 MAY INCLUDE PACKAGING PLACED BY THE MANUFACTURER AND PACKAGING PLACED
5 BY AN ENTITY AUTHORIZED TO REPACKAGE DRUGS IN THE STATE IN WHICH THE
6 ENTITY IS LOCATED;
7 (ii) The MEDICAL SUPPLIES ARE IN THEIR ORIGINAL UNOPENED
8 AND SEALED PACKAGING; AND
9 (III) THE prescription drugs, OVER–THE–COUNTER DRUGS, and
10 medical supplies are unadulterated, safe, and suitable for dispensing;
11 (7) [A standard form for health care practitioners to submit to a repository
12 to indicate a patient’s need for the Program;
13 (8)] A standard form that an individual receiving a prescription drug,
14 OVER–THE–COUNTER DRUG, or medical supply from [the Program] A REPOSITORY
15 LOCATED IN THE STATE must sign before receiving the drug or supply to confirm that the
16 individual understands that:
17 (i) The individual is receiving prescription drugs,
18 OVER–THE–COUNTER DRUGS, or medical supplies that have been donated to the Program;
19 and
20 (ii) Entities involved in the Program have certain immunity from
21 liability;
22 [(9)] (8) Record keeping and reporting requirements for a repository
23 LOCATED IN THE STATE; and
24 [(10)] (9) Any other standards and procedures the Board considers
25 appropriate FOR DROP–OFF SITES AND REPOSITORIES LOCATED IN THE STATE.
26 15–609.
27 (a) A repository LOCATED IN THE STATE shall:
28 (1) Maintain WRITTEN OR ELECTRONIC records of donated prescription
29 drugs, OVER–THE–COUNTER DRUGS, and medical supplies; and
30 (2) Submit periodic reports to the Board on its activities.

12 HOUSE BILL 1310
1 (b) To determine compliance with the requirements of this subtitle, the Board
2 shall:
3 (1) Inspect designated drop–off sites and repositories LOCATED IN THE
4 STATE;
5 (2) Inspect records of donated prescription drugs, OVER–THE–COUNTER
6 DRUGS, and medical supplies maintained by the repository REPOSITORIES LOCATED IN
7 THE STATE; and
8 (3) Beginning January 1, 2007, and each January 1 thereafter, report to
9 the Governor and, in accordance with § 2–1257 of the State Government Article, the
10 General Assembly on the operation of the Program.
11 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
12 October 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      ( w t G S a p t t G f h a t d o _ a _ o _ A P  F l i s t b d b t S B P r D s t p i t P a d s a r i o e f t B  A S]
[DELETED:  H   A  ( B  A S  A  (  S T A 1  ( I  ( “  ( D”E    )P D O M S I AN      )A––RTEC   “r ),  P I A D D O R P A  d   ( H v a t a d p dRTEC–     ( S TE     D o  ) “L”IY  O   (]()E” PT M A I WO TFAN T D D ,,,]
[DELETED: H 3  “  ()  ](   ( DS T L P I L I T TE  R A OTOFS L PY T AER–  ;   ( H   ( S TE     H    ( A d p d–ORTEC      ( D–RTECSE   ;    ( Ds ––RTEC m .()“T–”AREG      )M–ECMYCM YCM ,–     )M––TDIDS     )H    )IFG D     )IF H I A R M DE DN O R DY I D T R, ]
[DELETED:  H  1  ( T  ( T   ( As ––RTEC s ns; a   ( Asa––RTECS s 1  ( E t   ( P d i t ORTEC D o ue ] ;   ( M  ( T P m a a d p dRTEC   i  (  T),–RTEC     ()  B]()[]E( X A P I P  O TN    d   ()  M]( a   ()  B]( 1    )()TH R M A P D ARTEC]
[DELETED: H 5RTECGI–      )IIF T R A A P D ORTEC I H –()–RTECRTEC–  1  (  A p m d p d),–ORTEC     )TP R M R D P DSRTECS –,   ( Ps ––RTEC b at   ( A s T   ( R a d t c a s a d f r t ps ––RTEC   ( Ss ––RTEC m   ( F a t c o t d d s a d p ds a m s t a cl––,[ORTEC r  ( A m T   ( Ds––RTEC o   ( Rs ––RTEC s   ( C  )CBO OD  ]
[DELETED:  H     )MP– RPOE    )M, A D P DSRTEC DS A M S F A PN U–,   1  ( T   p  ( C     ( A o d p d–ORTEC     ( Is––RTEC a   ( A   ts ––RTEC t   ( Ds––RTEC a  i   ( M a s i o d p dRTEC–     ( Ss ––RTEC m   ( M s p f f p r d p   ( O sRTEC DSO–  a m s w o d .  ( A   T ds ––RTEC]
[DELETED: H 7   ( T 1( o   ( O m s   ( I    ( S    ( C  ( A   T   ( C a f n t e $ f e p dRTEC–     ( Dg––RTEC o m  ( A dg ––RTEC  ( As––RTEC a b  (B OD      )MP RY    )S, D D P DSRTECS  T–,      )FE    )IA O T S I W T E I L T S A D O P DSRTECS S –,      )SIT]
[DELETED:  H    T d  (   a G A t e i r d p d a m s  ()A, P DG TG O R P S ORTEC DS A M SS O F––,N R T ,   ) R L I A S O P T P O P I A D D O R M N B R T P A C O M O P DS ORTEC DS O M––   )A R L I T T M T DS RTECS ––,     )AS TE    )A–POE E  P I A D D O R P I L W L I T I N N F T D P DSRTEC DS O M S F U B E– TE ,   )N O P F L O L OD PO    )ISRTECS S –,    )T, O D P DSRTEC DS A M S F DPO S–, I A SE R L I A SE O]
[DELETED: H 9  1   T),– RTECSF A R L I T T  o m s , a i sl:   ( B   ( B ay t,] hr.  )T,O B E T R D P DSRTECS –E    1  ( T   ( A p t d p d–ORTEC     ( A   ( A   ( T   ( Ps    )PS    ) E B O V F A E R .  ( F   ds ––RTEC t P F T DN AE TR,F    t   ( C]
[DELETED:  H    ( L o  ( A d m a i g f m n b s t c p p f m r t t d a o d o a d m i o 1  ( O t s  ( T   ( C o d t a r w n a i a s   ( A s f e d T A DPO S T   i   ( R f d o d s t a d p ds a m s u t––ORTEC D P   ( R ds ––RTEC t   ( SPO T   d o d p ds a m––ORTEC D s   ( S a p f L I T,– R TO ORTEC  i d p d      ( T o     1 S]
[DELETED: H 1     2 I u p–RTECD D REG ,– A A      ( TG       p ds a)T,––IH  ORTEC D m   ( A t   () A s f t a i r a p dRTEC DGA R–,[  o m s f t Pm T   i    ( T i i r p dRTEC–   a    ( E i i t P h c i f l   () R k a r r f a r]( T ;   () A o s a p t B c]( a .PO T 1  ( A   T   ( M   ds ––RTEC   ( S]
[DELETED:  H   ( T s   ( I ;   ( I–RTECSR   T ;   ( B t G a i a w § 2 o t S G A t G  S A B I F E T t A s t e O          G               ]